A Clinical Study Exploring the Safety, Efficacy and Metabolic Kinetics of CT1182 Injection in Patients With Relapsed / Refractory Non Hodgkin Lymphoma
Conditions
- B-cell Non Hodgkin Lymphoma (NHL)
- DLBCL - Diffuse Large B Cell Lymphoma
- Follicular Lymphoma (FL)
Interventions
- BIOLOGICAL: CT1182 injection
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Collaborators